These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32619425)

  • 1. Neuropeptide signalling systems - An underexplored target for venom drug discovery.
    Mendel HC; Kaas Q; Muttenthaler M
    Biochem Pharmacol; 2020 Nov; 181():114129. PubMed ID: 32619425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
    Hoyer D; Bartfai T
    Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.
    Hallberg M
    Med Res Rev; 2015 May; 35(3):464-519. PubMed ID: 24894913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptides: opportunities for drug discovery.
    Hökfelt T; Bartfai T; Bloom F
    Lancet Neurol; 2003 Aug; 2(8):463-72. PubMed ID: 12878434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone-like peptides in the venoms of marine cone snails.
    Robinson SD; Li Q; Bandyopadhyay PK; Gajewiak J; Yandell M; Papenfuss AT; Purcell AW; Norton RS; Safavi-Hemami H
    Gen Comp Endocrinol; 2017 Apr; 244():11-18. PubMed ID: 26301480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidomics for the discovery and characterization of neuropeptides and hormones.
    Romanova EV; Sweedler JV
    Trends Pharmacol Sci; 2015 Sep; 36(9):579-86. PubMed ID: 26143240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venom peptides as therapeutics: advances, challenges and the future of venom-peptide discovery.
    Robinson SD; Undheim EAB; Ueberheide B; King GF
    Expert Rev Proteomics; 2017 Oct; 14(10):931-939. PubMed ID: 28879805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orphan peptide and G protein-coupled receptor signalling in alcohol use disorder.
    Anversa RG; Maddern XJ; Lawrence AJ; Walker LC
    Br J Pharmacol; 2024 Mar; 181(5):595-609. PubMed ID: 38073127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel neuropeptides as ligands of orphan G protein-coupled receptors.
    Zhang Y; Wang Z; Parks GS; Civelli O
    Curr Pharm Des; 2011; 17(25):2626-31. PubMed ID: 21728976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal toxins - Nature's evolutionary-refined toolkit for basic research and drug discovery.
    Herzig V; Cristofori-Armstrong B; Israel MR; Nixon SA; Vetter I; King GF
    Biochem Pharmacol; 2020 Nov; 181():114096. PubMed ID: 32535105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic Profile of Neuropeptide-Receptor Interactions.
    Nederpelt I; Bunnik J; IJzerman AP; Heitman LH
    Trends Neurosci; 2016 Dec; 39(12):830-839. PubMed ID: 27793433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orphan G protein-coupled receptors and obesity.
    Xu YL; Jackson VR; Civelli O
    Eur J Pharmacol; 2004 Oct; 500(1-3):243-53. PubMed ID: 15464037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptide ligands for peptidergic G protein-coupled receptors.
    Geary TG
    Adv Exp Med Biol; 2010; 692():10-26. PubMed ID: 21189672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakthroughs in Venom Peptide Screening Methods to Advance Future Drug Discovery.
    Napolitano T; Holford M
    Protein Pept Lett; 2018; 25(12):1137-1148. PubMed ID: 30381057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and In Vivo Characterisation of Cardioactive Peptides in
    Schiemann R; Lammers K; Janz M; Lohmann J; Paululat A; Meyer H
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in venom peptide drug discovery: where are we at and where are we heading?
    Smallwood TB; Clark RJ
    Expert Opin Drug Discov; 2021 Oct; 16(10):1163-1173. PubMed ID: 33914674
    [No Abstract]   [Full Text] [Related]  

  • 17. The Brugia malayi neuropeptide receptor-4 is activated by FMRFamide-like peptides and signals via Gαi.
    Anderson RC; Newton CL; Millar RP; Katz AA
    Mol Biochem Parasitol; 2014 Jun; 195(1):54-8. PubMed ID: 25038481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and Physiological Characterization of a Receptor for d-Amino Acid-Containing Neuropeptides.
    Checco JW; Zhang G; Yuan WD; Yu K; Yin SY; Roberts-Galbraith RH; Yau PM; Romanova EV; Jing J; Sweedler JV
    ACS Chem Biol; 2018 May; 13(5):1343-1352. PubMed ID: 29543428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiology of invertebrate oxytocin and vasopressin neuropeptides.
    Gruber CW
    Exp Physiol; 2014 Jan; 99(1):55-61. PubMed ID: 23955310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor.
    Elshourbagy NA; Ames RS; Fitzgerald LR; Foley JJ; Chambers JK; Szekeres PG; Evans NA; Schmidt DB; Buckley PT; Dytko GM; Murdock PR; Milligan G; Groarke DA; Tan KB; Shabon U; Nuthulaganti P; Wang DY; Wilson S; Bergsma DJ; Sarau HM
    J Biol Chem; 2000 Aug; 275(34):25965-71. PubMed ID: 10851242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.